Pennsylvania House unanimously approves bill to extend moratorium protecting seniors' eligibility for PACE and PACENET prescription drug programs through 2027.

April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.

The Supreme Court will rule on a critical ACA provision requiring private insurers to cover preventive health services without cost-sharing, impacting millions and insurance compliance.

Exploring the potential impacts of proposed HHS budget cuts on Medicaid and U.S. maternal health, highlighting concerns from healthcare experts about increasing health disparities.

Exploring the challenges and strategies for U.S. healthcare finance leaders in the transition to value-based care with the rise of Medicare Advantage and Medicaid Managed Care.

An analysis projects up to 5.2 million people could lose Medicaid coverage by 2026 if federal work requirements are enacted, adding tension to budgetary negotiations and healthcare access debates.

The Supreme Court examines the constitutionality of preventative health mandates under the ACA, affecting insurance coverage for millions. Insights into Humana's Medicare ratings and new healthcare affiliations included.

Novant Health Mint Hill Medical Center in North Carolina receives national acclaim with Everest Award and Top 100 Hospitals listing, highlighting its commitment to outstanding patient care and operational excellence.

President Trump's latest executive order modifies the Medicare Drug Price Negotiation Program, aligning the treatment of small molecule drugs with biologics and aiming to reduce drug prices.

President Trump signed an executive order to lower Medicare drug prices by enhancing drug price negotiations, increasing market transparency, and targeting anti-competitive behaviors.